Showing results (91-100 of 185) with videos related to
Sort By:
Pageof 19
BMJ Open|January 1, 2020
AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adultsHelen Marshall, Mark McMillan, Bing Wang, et al.Lancet (London, England)|February 1, 2021
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trialPeter Richmond, Lara Hatchuel, Min Dong, et al.Journal of Medical Microbiology|August 22, 2014
Serological versus molecular typing of surface-associated immune evading polysaccharide antigens-based phenotypes of Staphylococcus aureusCharlene B Waryah, Jully Gogoi-Tiwari, Kelsi Wells, et al.The Pediatric Infectious Disease Journal|September 16, 2015
Five-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine in Haemophilus influenzae Type B-primed ToddlersRobert Booy, Terry Nolan, Graham Reynolds, et al.NPJ Vaccines|January 15, 2022
Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathyPaola Villanueva, Ushma Wadia, Nigel Crawford, et al.BMJ Open|February 27, 2019
Geographical disparities in emergency department presentations for acute respiratory infections and risk factors for presenting: a population-based cohort study of Western Australian childrenRosanne Barnes, Christopher C Blyth, Nicholas de Klerk, et al.Human Vaccines & Immunotherapeutics|May 24, 2012
Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trialsKristina Bryant, Jodie McVernon, Colin Marchant, et al.Plos One|April 28, 2017
Human alkaline phosphatase dephosphorylates microbial products and is elevated in preterm neonates with a history of late-onset sepsisMatthew Pettengill, Juan D Matute, Megan Tresenriter, et al.Plos One|May 11, 2018
Correction: Human alkaline phosphatase dephosphorylates microbial products and is elevated in preterm neonates with a history of late-onset sepsisMatthew Pettengill, Juan D Matute, Megan Tresenriter, et al.Plos One|June 3, 2022
The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccinesPaola Villanueva, Ushma Wadia, Nigel W Crawford, et al.Pageof 19